188 related articles for article (PubMed ID: 28841206)
21. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype.
El-Sharnouby JA; Ahmed LM; Taha AM; Kamal O
Egypt J Immunol; 2008; 15(1):131-43. PubMed ID: 20306678
[TBL] [Abstract][Full Text] [Related]
22. FLT3 and NPM1 mutations in a cohort of AML patients and detection of a novel mutation in tyrosine kinase domain of FLT3 gene from Western India.
Ghosh K; Swaminathan S; Madkaikar M; Gupta M; Kerketta L; Vundinti B
Ann Hematol; 2012 Nov; 91(11):1703-12. PubMed ID: 22733614
[TBL] [Abstract][Full Text] [Related]
23. De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study.
Hasserjian RP; Campigotto F; Klepeis V; Fu B; Wang SA; Bueso-Ramos C; Cascio MJ; Rogers HJ; Hsi ED; Soderquist C; Bagg A; Yan J; Ochs R; Orazi A; Moore F; Mahmoud A; George TI; Foucar K; Odem J; Booth C; Morice W; DeAngelo DJ; Steensma D; Stone RM; Neuberg D; Arber DA
Am J Hematol; 2014 Nov; 89(11):E193-9. PubMed ID: 25042343
[TBL] [Abstract][Full Text] [Related]
24. Risk assessment in patients with acute myeloid leukemia and a normal karyotype.
Bienz M; Ludwig M; Leibundgut EO; Mueller BU; Ratschiller D; Solenthaler M; Fey MF; Pabst T
Clin Cancer Res; 2005 Feb; 11(4):1416-24. PubMed ID: 15746041
[TBL] [Abstract][Full Text] [Related]
25. miR‑188 suppresses tumor progression by targeting SOX4 in pediatric osteosarcoma.
Pan L; Meng L; Liang F; Cao L
Mol Med Rep; 2018 Jul; 18(1):441-446. PubMed ID: 29749512
[TBL] [Abstract][Full Text] [Related]
26. SOX4 is associated with poor prognosis in cholangiocarcinoma.
Wang W; Zhang J; Zhan X; Lin T; Yang M; Hu J; Han B; Hu S
Biochem Biophys Res Commun; 2014 Sep; 452(3):614-21. PubMed ID: 25181339
[TBL] [Abstract][Full Text] [Related]
27. miR-155 regulative network in FLT3 mutated acute myeloid leukemia.
Salemi D; Cammarata G; Agueli C; Augugliaro L; Corrado C; Bica MG; Raimondo S; Marfia A; Randazzo V; Dragotto P; Di Raimondo F; Alessandro R; Fabbiano F; Santoro A
Leuk Res; 2015 Aug; 39(8):883-96. PubMed ID: 26055960
[TBL] [Abstract][Full Text] [Related]
28. High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study.
Marcucci G; Maharry K; Whitman SP; Vukosavljevic T; Paschka P; Langer C; Mrózek K; Baldus CD; Carroll AJ; Powell BL; Kolitz JE; Larson RA; Bloomfield CD;
J Clin Oncol; 2007 Aug; 25(22):3337-43. PubMed ID: 17577018
[TBL] [Abstract][Full Text] [Related]
29. [Detection of NPM1, FLT3 and C-KIT mutations in acute myeloid leukemia and their prognostic analysis].
Li L; Lyu XD; Mi RH; Ding J; Chen L; Wang Q; Yin QS; Hu JY; Fan RH; Wei XD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):601-6. PubMed ID: 23815906
[TBL] [Abstract][Full Text] [Related]
30. Association of SOX4 regulated by tumor suppressor miR-30a with poor prognosis in low-grade chondrosarcoma.
Lu N; Lin T; Wang L; Qi M; Liu Z; Dong H; Zhang X; Zhai C; Wang Y; Liu L; Xiang L; Qi L; Han B; Li J
Tumour Biol; 2015 May; 36(5):3843-52. PubMed ID: 25572678
[TBL] [Abstract][Full Text] [Related]
31. Bone marrow miR-10a overexpression is associated with genetic events but not affects clinical outcome in acute myeloid leukemia.
Zhang TJ; Guo H; Zhou JD; Li XX; Zhang W; Ma JC; Wen XM; Yao XY; Lin J; Qian J
Pathol Res Pract; 2018 Jan; 214(1):169-173. PubMed ID: 29254789
[TBL] [Abstract][Full Text] [Related]
32. Sox4 cooperates with PU.1 haploinsufficiency in murine myeloid leukemia.
Aue G; Du Y; Cleveland SM; Smith SB; Davé UP; Liu D; Weniger MA; Metais JY; Jenkins NA; Copeland NG; Dunbar CE
Blood; 2011 Oct; 118(17):4674-81. PubMed ID: 21878674
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of immunophenotyping and gene mutations in elderly patients with acute myeloid leukemia with normal karyotype.
Dang H; Jiang A; Kamel-Reid S; Brandwein J; Chang H
Hum Pathol; 2013 Jan; 44(1):55-61. PubMed ID: 22939316
[TBL] [Abstract][Full Text] [Related]
34. SOX4 is overexpressed in diffusely infiltrating astrocytoma and confers poor prognosis.
Li L; Li Q; Chen X; Xu M; Li X; Nie L; Chen N; Gong J; Mao Q; Zhou Q
Neuropathology; 2015 Dec; 35(6):510-7. PubMed ID: 26096696
[TBL] [Abstract][Full Text] [Related]
35. MOZ/TIF2-induced acute myeloid leukaemia in transgenic fish.
Zhuravleva J; Paggetti J; Martin L; Hammann A; Solary E; Bastie JN; Delva L
Br J Haematol; 2008 Nov; 143(3):378-82. PubMed ID: 18729850
[TBL] [Abstract][Full Text] [Related]
36. SOX4 enables oncogenic survival signals in acute lymphoblastic leukemia.
Ramezani-Rad P; Geng H; Hurtz C; Chan LN; Chen Z; Jumaa H; Melnick A; Paietta E; Carroll WL; Willman CL; Lefebvre V; Müschen M
Blood; 2013 Jan; 121(1):148-55. PubMed ID: 23152540
[TBL] [Abstract][Full Text] [Related]
37. A crucial epithelial to mesenchymal transition regulator, Sox4/Ezh2 axis is closely related to the clinical outcome in pancreatic cancer patients.
Hasegawa S; Nagano H; Konno M; Eguchi H; Tomokuni A; Tomimaru Y; Asaoka T; Wada H; Hama N; Kawamoto K; Marubashi S; Nishida N; Koseki J; Mori M; Doki Y; Ishii H
Int J Oncol; 2016 Jan; 48(1):145-52. PubMed ID: 26648239
[TBL] [Abstract][Full Text] [Related]
38. NPM1 and FLT3 mutations in acute myeloid leukemia with normal karyotype: Indian perspective.
Sazawal S; Singh N; Jain S; Chhikara S; Chaubey R; Bhattacharyya J; Saikia KK; Mahapatra M; Saxena R
Indian J Pathol Microbiol; 2017; 60(3):355-359. PubMed ID: 28937371
[TBL] [Abstract][Full Text] [Related]
39. Clinical and prognostic implications of Roundabout 4 (robo4) in adult patients with acute myeloid leukemia.
Chen YK; Hou HA; Tang JL; Jhuang JY; Lai YJ; Lee MC; Kuo YY; Chou WC; Liu CY; Lin CW; Chuang SS; Chen CY; Tseng MH; Huang CF; Chiang YC; Lee FY; Liu MC; Liu CW; Yao M; Huang SY; Ko BS; Hsu SC; Wu SJ; Tsay W; Chen YC; Tien HF
PLoS One; 2015; 10(3):e0119831. PubMed ID: 25794001
[TBL] [Abstract][Full Text] [Related]
40. CD123 immunohistochemical expression in acute myeloid leukemia is associated with underlying FLT3-ITD and NPM1 mutations.
Rollins-Raval M; Pillai R; Warita K; Mitsuhashi-Warita T; Mehta R; Boyiadzis M; Djokic M; Kant JA; Roth CG
Appl Immunohistochem Mol Morphol; 2013 May; 21(3):212-7. PubMed ID: 22914610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
